In April 2020, RESTEM Biotechnology and Baptist Health South Florida, a nonprofit healthcare organization, announced that three COVID-19 patients with acute respiratory distress syndrome were the first to be successfully treated with umbilical cord mesenchymal stem cells in the United States.